| Literature DB >> 31592307 |
Sumanth Gunupati1, Hasya Sappiti1, Sreenivas Nagarakanti1, Bv Ramesh Reddy1, Vijay Kumar Chava1.
Abstract
Background. Elevated temperature has been recognized as an inflammatory sign. It is the only indication that can be both objectively and quantitatively evaluated and is considered as a potential indicator of periodontal disease. Assessing gingival surface temperature (GST) could be a diagnostic parameter to determine periodontal health. This pilot clinical study aimed to validate gingival surface temperature (GST) as a clinical diagnostic tool to measure periodontal disease activity by correlating with the periodontal inflamed surface area (PISA). Methods. A cross-sectional mono-center pilot study was conducted with a convenient sample of 50 participants with a mean age of 34.14±13.7 years. Clinical parameters such as probing pocket depth (PPD) clinical attachment loss (CAL) and bleeding on probing (BOP) were measured. GST was recorded with a single lead of the bedside patient monitor and correlated with PISA. Results. The results showed a positive correlation between PISA and GST (P=0.46). Conclusion. This study showed a rise in GST of inflamed sites, but the results did not support the hypothesis that increased GST is an indicator of periodontal disease. As this is a pilot study, further studies with more larger sample sizes need to be undertaken to confirm its use as a diagnostic tool in clinical trials.Entities:
Keywords: Diagnosis; gingiva; inflammation; periodontal diseases; periodontitis; temperature
Year: 2019 PMID: 31592307 PMCID: PMC6773919 DOI: 10.15171/joddd.2019.019
Source DB: PubMed Journal: J Dent Res Dent Clin Dent Prospects ISSN: 2008-210X
Figure 1Demographic data
|
|
| |
|
|
| |
| 34.14±13.7 | 32 | 18 |
Correlation between PISA, PESA, GST
|
|
|
| ||
|
|
| 1.00 | 0.91 | 0.11 |
|
| <0.001 | 0.46 (NS) | ||
|
|
| 1.00 | 0.03 | |
|
| 0.84(NS) |
Spearman’s correlation test
*P<0.05, statistically significant
P>0.05, non-significant (NS)
Multiple linear regression
|
|
|
| |||
|
|
|
|
| ||
|
| -8553.85 | 5023.1 | 0.10 (NS) | -18677.24 | 1569.54 |
|
| 0.70 | 5.09 | 0.89 (NS) | -9.56 | 10.96 |
|
| 175.99 | 90.30 | 0.06 (NS) | -6.00 | 357.99 |
|
| -24.1 | 121.65 | 0.84 (NS) | -269.27 | 221.07 |
|
| 203.16 | 137.76 | 0.15 (NS) | -74.49 | 480.8 |
|
| 1.15 | 0.06 | <0.001* | 1.02 | 1.28 |
Dependent variable: PISA
ANOVA, F(5,44)=119.02, P<0.001*
R2=0.97 *P<0.05 statistically significant
P>0.05 Non-significant, (NS)
Each subject was evaluated concerning PPD, CAL and the number of bleeding sites; PISA and PESA were calculated by filling the spreadsheets (freely available from www.parsprototo.info.) described by Hujoel et al.[14]
Figure 2Sensitivity and specificity of PISA, PESA and GST
|
|
|
|
|
|
|
| ||
|
|
| |||||||
| PISA | 509.8 | 0.90 | 1.00 | 0.98 | 0.02 | <0.001* | 0.95 | 1.00 |
| PESA | 1294.985 | 0.90 | 1.00 | 0.93 | 0.04 | <0.001* | 0.86 | 1.00 |
| GST | 35.9865 | 0.72 | 0.64 | 0.61 | 0.10 | 0.28 (NS) | 0.42 | 0.80 |
*P<0.05, statistically significant
P>0.05, non-significant (NS)